We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cholesterol Analogs Block Growth of Tuberculosis Bacteria

By LabMedica International staff writers
Posted on 21 Apr 2016
Print article
Image: A high magnification (15,549x) scanning electron micrograph (SEM) showing a number of Gram-positive Mycobacterium tuberculosis bacteria (Photo courtesy of the CDC).
Image: A high magnification (15,549x) scanning electron micrograph (SEM) showing a number of Gram-positive Mycobacterium tuberculosis bacteria (Photo courtesy of the CDC).
Analogs of cholesterol that have been modified by the addition of non- degradable side chains have been shown to inhibit the growth of Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB).

Investigators at the University of Queensland (Brisbane, Australia) and the University of California, San Francisco (USA) had previously found that the cholesterol derivative cholest-4-en-3-one, whether added or generated intracellularly from cholesterol, inhibited the growth of M. tuberculosis when the cytochrome P450 enzymes (CYP125A1 and CYP142A1) that initiate degradation of the sterol side chain were disabled.

Continuing this line of research, they reported in the April 1, 2016, issue of the Journal of Biological Chemistry that a 16-hydroxy derivative of cholesterol, which was previously shown to inhibit growth of M. tuberculosis, acted by preventing the oxidation of the sterol side chain even in the presence of the relevant cytochrome P450 enzymes. The finding that (25R)-cholest-5-en-3beta,16beta,26-triol (1) (and its 3-keto metabolite) inhibited growth suggested that cholesterol analogs with non-degradable side chains represented a novel class of anti- mycobacterial agents.

To confirm this speculation, the investigators synthesized two cholesterol analogs with truncated, fluorinated side chains and demonstrated that these compounds could block the growth of M. tuberculosis in culture.

Contributing author Dr. James De Voss, professor of chemistry and molecular biosciences at the University of Queensland said, "If you give this bacterium modified cholesterol instead, then it cannot use it as its energy source and so it stops growing. Interestingly, we do not quite understand why this happens. Our discovery suggests a new way in which we can robustly inhibit growth of the TB bacterium."

Related Links:
University of Queensland
University of California, San Francisco

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.